Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $0.84, $0.10 better than the analyst estimate of $0.74. Revenue for the quarter came in at $4.93 billion versus the consensus estimate of $4.72 billion.

GUIDANCE:

Bristol-Myers Squibb sees FY2017 EPS of $2.85-$3.00, versus the consensus of $2.80.

For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.